# Methoxy Polyethylene Glycol- Epoetin β

## Mircera inj 50mcg/0.3mL

| 藥物代碼           | IMIR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Treatment of symptomatic anemia associated with chronic kidney disease (CKD). Not indicated for the treatment of anemia due to cancer chemotherapy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 副作用             | Hypertension, diarrhea, nasopharyngitis, headache & upper respiratory tract infections. Increased mortality, serious cardiovascular & thromboembolic events; Increased mortality and/or tumor progression; seizures; pure red cell aplasia.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 禁忌               | Uncontrolled hypertension.Neonates: injections containing benzyl alcohol.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 藥物保存方式       | 2-8℃                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 用法用量           | The dose should be reduced as the Hb approaches 12 g/dL or increases by > 1 g/dL in any 2-week period. Adult not currently treated with an ESA Initially 0.6 mcg/kg as a single IV/SC once every 2 weeks. Once Hb has been maintained within 10-12 g/dL, it may be administered once monthly using a dose that is twice that of the every-2-week dose & subsequently titrated as necessary. Adult currently treated with an ESA Initially administered as single IV/SC once every 2 weeks or once monthly to patients whose Hb has been stabilized: Previous weekly Epoetin α or β < 4000 u/week or Darbepoetin α < 20 mcg/week 80 mcg/mth or 40 mcg every 2 weeks. Previous weekly Epoetin α or β 4000-< 8000 u/week or Darbepoetin α 20-< 40 mcg/week 120 mcg/mth or 60 mcg every 2 weeks. Previous weekly Epoetin α or β 8000-16000 u/week or Darbepoetin α 40-80 mcg/week 200 mcg/mth or 100 mcg every 2 weeks. Previous weekly Epoetin α or β > 16000 u/week or Darbepoetin α > 80 mcg/week 360 mcg/mth or 180 mcg every 2 weeks. Dose adjustments should not be made more often than once a month. |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 懷孕用藥危分級     | 尚未確立                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 孕期用藥建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 哺乳期用藥建議     | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 注射劑給藥建議途徑 | IV, SC                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 注意事項           | Intravenous: Inject into the venous port of the hemodialysis tubing. SC: Inject into the outer aspect of the upper arms, abdomen (except for 2 inches around the navel), or front aspect of the middle thighs. Do not inject into an area that has scars or stretch marks or is tender, red, bruised, or hard. Rotate injection sites with each injection to prevent soreness.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

